Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma

Yvonne A. Dei-Adomakoh, Jane S. Afriyie-Mensah, Hafisatu Gbadamosi

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

We report a case of a young Ghanaian male who developed Bleomycin Induced Pneumonitis (BIP) after being treated for Hodgkin's Lymphoma. Pulmonary toxicity is the most feared complication of bleomycin therapy despite its effectiveness in achieving cure in patients with Hodgkin's lymphoma and germ cell tumors. BIP has a significant mortality rate if detected late and a high index of suspicion is required in all patients on bleomycin-based therapies with sudden onset of respiratory symptoms.

Original languageEnglish
Pages (from-to)279-283
Number of pages5
JournalGhana Medical Journal
Volume54
Issue number4
DOIs
Publication statusPublished - Dec 2020

Keywords

  • Bleomycin
  • Ghana
  • Hodgkin's lymphoma
  • Pneumonitis

Fingerprint

Dive into the research topics of 'Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma'. Together they form a unique fingerprint.

Cite this